In recent months there has been a sharp rise in the number of illegal medicines marketed as GLP-1 receptor agonists such as semaglutide, liraglutide and tirzepatide for weight loss and diabetes
It is currently available only on iOS
Methods: According to the Rapid Guide for Drug Evaluation and Selection in Chinese Medical Institutions (Second Edition) released in 2023, relevant databases such as PubMed, Cochrane, and Embase, drug labels, and clinical guidelines were searched for drug information
The publisher is not responsible for pricing changes, expired promotional offers, or pricing discrepancies between this article and altRx's current published pricing
Both medications work to control blood sugar, regulate appetite, and aid in weight loss
PMC12634801 Paschou IA, Sali E, Paschou SA, Psaltopoulou T, Nicolaidou E, Stratigos AJ